Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
Conditions
- NHL
- DLBCL - Diffuse Large B Cell Lymphoma
Interventions
- DRUG: ARI-0001
- DRUG: Axi-cel
Sponsor
University Medical Center Groningen
Collaborators